The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use?
Abstract
Aims: Antihistamines are routinely taken to control allergic reactions or sedation to induce sleep. There are, however, growing concerns regarding sedating antihistamine misuse. This research aims to evaluate deaths related to antihistamines in England occurring during 2000–2019. Methods: Cases reported to the National Programme on Substance Abuse Deaths from England occurring in 2000–2019 with antihistamine detections at postmortem were extracted for analysis. Results: In total, 1666 antihistamine postmortem detections were identified from 1537 cases. Sedating antihistamines available for purchase under pharmacist supervision but without need for a prescription (pharmacy‐only medications) were present in a significant majority of cases (85.2%, P < .01). Despite an increasing trend for antihistamine‐related deaths over time, the proportion of deaths where an antihistamine was implicated declined over the same period. Specific concerns with regards to the misuse of these pharmacy‐only sedating antihistamines are raised with regards to the significant proportion of cases that were concluded as suicide (20.9%, P < .01), and the high prevalence of their use in combination with other central nervous system depressants (94.8% of cases). Conclusion: This is the first report in over 40 years regarding antihistamine‐related mortality from England. The rising trend in sedating antihistamine‐related deaths may be contributed to by their increasing availability and the perceived negligible dangers associated with antihistamines, both from the general public and learned professionals. Awareness of the dangerous sedative properties that some antihistamines possess is, however, heightened in individuals deliberately seeking these effects. Urgent review of sedating antihistamines currently assigned under the pharmacy‐only classification is needed to achieve antihistamine harm reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently published evidence (Oyekan et al., 2021), indicating an association of antihistamines with increased mortality, suggests further caution.”
From The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 (2023) · cites this paper as Oyekan et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sleep and mental disorders: a meta-analysis of polysomnographic research
Baglioni, C., Nanovska, S., Regen, W., Spiegelhalder, K., Feige, B., Nissen, C., Reynolds, C. F., & Riemann, D. (2016) · Psychological Bulletin · doi:10.1037/bul0000053 · Cited by 1,074
Gunnell, D., Bennewith, O., Simkin, S., Cooper, J., Klineberg, E., Rodway, C., Sutton, L., Steeg, S., Wells, C., Hawton, K., et al. (2013) · Psychological Medicine · doi:10.1017/s0033291712002401 · Cited by 111 · cited 1×
“Whilst a significant proportion of antihistamine-related deaths were concluded as suicide, the true proportion is probably higher than that reported and therefore of even greater concern: a significant proportion of deaths concluded as undetermined intent are likely to have been suicide(26); there is an increasing tre…”
ResultSpiller, H. A., Ackerman, J. P., Smith, G. A., Kistamgari, S., Funk, A. R., McDermott, M. R., & Casavant, M. J. (2020) · Clinical Toxicology · doi:10.1080/15563650.2019.1665182 · Cited by 110
Research works printed but not linked: 48
- 10.1007/164_2016_85 · DOI
- 10.1016/S0301-0082(00)00039-3 · DOI · Paper page
- 10.2500/108854188778965528 · doi:10.2500/108854188778965528
- Veronika C, 2016, Safety risks of over‐the‐counter (OTC) drugs and their management, Acta Pharm Hung, 86, 151
- 10.14423/SMJ.0000000000000256 · DOI
- Hedegaard H, 2019, Regional Differences in the Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017, Natl Vital Stat Rep, 68, 1
- 10.1111/sltb.12525 · DOI
- 10.1016/j.forsciint.2016.10.024 · doi:10.1016/j.forsciint.2016.10.024
- 10.3346/jkms.2013.28.10.1424 · doi:10.3346/jkms.2013.28.10.1424
- 10.1016/j.jflm.2013.06.027 · DOI
- 10.1016/j.forsciint.2006.08.002 · DOI
- 10.1016/j.forsciint.2017.11.026 · doi:10.1016/j.forsciint.2017.11.026
- 10.1371/journal.pone.0161996 · doi:10.1371/journal.pone.0161996
- 10.1097/MCG.0000000000000378 · DOI
- 10.1016/j.forsciint.2015.09.021 · DOI
- 2019, Deaths related to drug poisoning in England and Wales: 2018 registrations
- 10.1136/bmj.280.6231.1595 · doi:10.1136/bmj.280.6231.1595
- 10.1093/jat/bku066 · doi:10.1093/jat/bku066
- 10.1093/jat/31.9.581 · doi:10.1093/jat/31.9.581
- BNF, 2020, British National Formulary 79: April 2020‐ March 2021
- Mackridge A, 2013, Time to rethink our approach to misuse of over the counter medicines, Pharm J, 290, 107
- 2020, Suicides in England and Wales: 2019 registrations
- Wright J, 2016, Changes in over‐the‐counter drug misuse over 20 years: perceptions from Scottish pharmacists, J Public Health (Oxf), 38, 793
- 10.3122/jabfm.2008.01.070071 · DOI · Paper page
- 10.2165/00002018-200124140-00002 · DOI · Paper page
- 10.2165/00002018-200326150-00001 · doi:10.2165/00002018-200326150-00001
- 10.3109/14659891.2011.615002 · DOI · Paper page
- 10.1097/ADM.0000000000000124 · doi:10.1097/adm.0000000000000124
- 10.1097/ADM.0b013e31827f9b43 · DOI
- 10.1016/j.drugalcdep.2015.02.023 · doi:10.1016/j.drugalcdep.2015.02.023
- 10.1080/02791072.2020.1797250 · DOI
- 10.1177/0269881120959615 · DOI
- Southard BT, 2020, StatPearls
- Sicari V, 2020, StatPearls
- 10.1177/106002808401800905 · DOI
- 10.1007/s12098-019-02894-8 · doi:10.1007/s12098-019-02894-8
- 10.1007/s40278-015-6643-7 · doi:10.1007/s40278-015-6643-7
- 10.1186/1477-7517-11-17 · doi:10.1186/1477-7517-11-17
- 10.1111/j.1360-0443.2006.01688.x · DOI
- 10.1111/add.13843 · DOI · Paper page
- 10.1097/ACI.0000000000000556 · doi:10.1097/aci.0000000000000556
- 10.1111/j.1398-9995.2009.02325.x · DOI · Paper page
- WHO, 2020, Opioid overdose
- 10.1192/bjp.187.3.206 · DOI
- 10.1136/bmj.f403 · DOI · Paper page
- 10.1080/10837450902891485 · DOI
- 10.2165/00003088-198916050-00003 · DOI
- Alexander SPH, 2019, THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors, Br J Pharmacol, 176, S21
Cited by
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14035 · Cited by 834
“Recently published evidence (Oyekan et al., 2021), indicating an association of antihistamines with increased mortality, suggests further caution.”
BackgroundCan cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)
Rock, K. L., Englund, A., Morley, S., Rice, K., & Copeland, C. S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221115760 · Cited by 32
Self-citation
Metadata
- Authors
- Oyekan, P. J., Gorton, H. C., & Copeland, C. S.
- Affiliations
- Institute of Pharmaceutical Sciences King's College London London UK
- Department of Pharmacy, School of Applied Sciences University of Huddersfield Huddersfield UK
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2021-03-31
- Volume
- 87
- Issue
- 10
- Pages
- 3978-3987
- ISSN
- 0306-5251
- 1365-2125
- Cited by
- 35
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use? https://app.cochat.ai/papers/10.1111/bcp.14819
- The paper
- Oyekan, P. J., Gorton, H. C., & Copeland, C. S. (2021). Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use? British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14819
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.